Drug Guidance for Subsidy 01/04/2022 High-strength insulin glargine for treating type 1 and 2 diabetes mellitus NRThe Ministry of Health’s Drug Advisory Committee has not recommended listing insulin glargin... See all × 01/04/2022 High-strength insulin glargine for treating type 1 and 2 diabetes mellitus NRThe Ministry of Health’s Drug Advisory Committee has not recommended listing insulin glargine 300 units/ml on the Standard Drug List (SDL) for treating type 1 and 2 diabetes mellitus in view of unfavourable cost-effectiveness compared with insulin glargine 100 units/ml at the price proposed by the manufacturer, and low clinical need.
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Toujeo Injection, Solution 300 units/mL Alexandra Hospital Changi General Hospital National University Hospital Singapore General Hospital Tan Tock Seng Hospital
SUBCUTANEOUS Select a brand starting with the letter: T TOUJEO SOLOSTAR 300 UNITS/ML SOLUTION FOR INJECTION IN A PRE-FILLED PEN [SIN15138P]